What Are the Challenges and Risks of Cancer Nanotechnology?
Despite its potential, cancer nanotechnology faces several challenges, including:
Toxicity and Safety: The small size and high reactivity of nanoparticles may pose toxicity risks to healthy tissues, necessitating thorough biocompatibility studies. Targeting Efficiency: Ensuring nanoparticles consistently reach and penetrate tumors without being cleared by the immune system is a significant challenge. Regulatory Hurdles: The complexity and novelty of nanotechnology-based therapies can complicate the regulatory approval process, requiring extensive testing and validation.
